Crinetics Pharmaceuticals
CRNX
CRNX
85 hedge funds and large institutions have $429M invested in Crinetics Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 33 increasing their positions, 15 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
10% less capital invested
Capital invested by funds: $475M → $429M (-$46.5M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
85
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$10.1M | |
| 2 | +$8.17M | |
| 3 | +$4.44M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$4.43M |
| 5 |
Morgan Stanley
New York
|
+$2.05M |
Top Sellers
| 1 | -$24.9M | |
| 2 | -$13.4M | |
| 3 | -$3.76M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$784K |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$600K |